ArticleSports medicine (Auckland, N.Z.)2025
The Association Between Age of First Exposure to American Football at a Young Age and Later-Life Health Issues in Healthy, Community-Dwelling Adults.
Article in Sports medicine (Auckland, N.Z.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Younger Age of First Exposure to American Football Is Associated with Worse Informant-Reported Clinical Outcomes in Older Age Brain Donors.Journal of neurotrauma · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionYounger age of first exposure (AFE) to American Football (football) is associated with later-life health problems among former professional athletes in several studies; however, studies examining amateur (i.e., nonprofessional) athletes are less clear.
objectiveIn a cohort of former amateur American Football players, this study assessed whether AFE to football was associated with: (1) psychiatric and neurobehavioral symptoms, (2) cognitive difficulties, (3) general health problems, (4) motor symptoms, and (5) functional status.
methodsA cross-sectional survey study was conducted using the ResearchMatch platform. The key independent variable was age of first exposure to football (AFE < 12 versus AFE ≥ 12). Main outcomes included depressive symptoms (Patient Health Questionnaire-9; PHQ-9), anxiety symptoms (Generalized Anxiety Disorders-7; GAD-7), cognitive difficulties (British Columbia Cognitive Complaints Inventory; BC-CCI), Neurobehavioral Symptom Inventory (NSI) score, and prevalence of other health problems. Multivariable regressions were assessed for associations between AFE and outcome variables.
resultsIn total, 107 male participants with exposure to football (mean age: 60.6 ± 15.1 years) reported an average of 4.2 ± 2.7 years of exposure to football, with an average AFE of 11.7 ± 3.1 years. In multivariable analyses, AFE < 12 was not a significant predictor of PHQ-9 (unstandardized beta, B: 0.51, standard error, SE: 1.25, p = 0.682), GAD-7 (B: 0.09, SE: 0.95, p = 0.926), NSI (B: - 0.56, SE: 2.93, p = 0.850), or BC-CCI (B: - 0.65, SE: 0.77, p = 0.403). However, more prior concussions were associated with worse PHQ-9 (B: 0.44, SE: 0.10, p < 0.001), GAD-7 (B: 0.33, SE: 0.07, p < 0.001), NSI (B: 1.04, SE: 0.23, p < 0.001), and BC-CCI scores (B: 0.26, SE: 0.06, p < 0.001). AFE < 12 did not predict general health problems or independent functional status.
conclusionsAFE to football was not associated with adverse psychiatric, cognitive, neurobehavioral, or general health outcomes among young, former amateur American Football players. However, more lifetime concussions were associated with adverse cognitive and psychiatric health outcomes. Future studies should examine similar outcomes in older cohorts with more comorbidities to further minimize potential confounding between general health and lack of later-life symptoms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.